Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BPX-501
BPX-501
Bellicum Pharmaceuticals Rakes in $69 Million - Closes Public Offering
Sat, 04/21/18 - 12:49 pm
Bellicum
BPX-501
Bellicum Shares Up After Clinical Hold lifted on BPX-501
CP Wire
Thu, 04/12/18 - 12:13 am
Bellicum
BPX-501
FDA
clinical trials
Bellicum Shares Up After Clinical Hold lifted on BPX-501
Wed, 04/11/18 - 10:32 pm
Bellicum
BPX-501
Bellicum Pharmaceuticals Faces Clinical Hold After Three Patients Suffer Brain Damage
Xtalks
Thu, 02/1/18 - 09:30 am
Bellicum
clinical trials
BPX-501
hematologic cancers
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants
TheStreet.com
Sun, 12/6/15 - 10:02 am
Bellicum
stem cells
BPX-501
t cell therapy